CAW
NVO

Cornerstone Advisors (Washington)’s Novo Nordisk NVO Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$509K Buy
14,666
+164
+1% +$5.47K 0.05% 44
2020
Q2 		$475K Buy
14,502
+1,768
+14% +$56.4K 0.05% 44
2020
Q1 		$383K Buy
12,734
+364
+3% +$10.8K 0.05% 38
2019
Q4 		$358K Buy
12,370
+402
+3% +$11.1K 0.04% 55
2019
Q3 		$309K Buy
11,968
+20
+0.2% +$506 0.04% 57
2019
Q2 		$305K Buy
11,948
+570
+5% +$14.1K 0.03% 96
2019
Q1 		$298K Buy
11,378
+2,864
+34% +$70.4K 0.03% 93
2018
Q4 		$196K Buy
8,514
+116
+1% +$2.58K 0.04% 124
2018
Q3 		$198K Buy
8,398
+266
+3% +$6.49K 0.13% 131
2018
Q2 		$188K Buy
8,132
+178
+2% +$4.23K 0.13% 131
2018
Q1 		$196K Buy
7,954
+840
+12% +$22.1K 0.13% 124
2017
Q4 		$191K Buy
7,114
+324
+5% +$8.24K 0.13% 119
2017
Q3 		$163K Sell
6,790
-260
-4% -$5.88K 0.11% 142
2017
Q2 		$151K Buy
7,050
+6,516
+1,220% +$131K 0.08% 143
2017
Q1 		$9K Sell
534
-30
-5% -$522 ﹤0.01% 590
2016
Q4 		$10K Sell
564
-10,032
-95% -$182K 0.01% 597
2016
Q3 		$220K Sell
10,596
-534
-5% -$13.2K 0.19% 74
2016
Q2 		$299K Sell
11,130
-2
-0% -$55 0.3% 42
2016
Q1 		$302K Sell
11,132
-124
-1% -$3.32K 0.32% 41
2015
Q4 		$327K Sell
11,256
-8,572
-43% -$237K 0.36% 31
2015
Q3 		$538K Buy
19,828
+1,070
+6% +$30.3K 0.47% 20
2015
Q2 		$514K Hold
18,758
– – 0.42% 25
2015
Q1 		$501K Buy
18,758
+36
+0.2% +$829 0.39% 29
2014
Q4 		$396K Buy
18,722
+17,332
+1,247% +$387K 0.29% 56
2014
Q3 		$33K Hold
1,390
– – 0.03% 96
2014
Q2 		$32K Hold
1,390
– – 0.03% 112
2014
Q1 		$32K Hold
1,390
– – 0.04% 102
2013
Q4 		$26K Hold
1,390
– – 0.04% 94
2013
Q3 		$24K Hold
1,390
– – 0.04% 94
2013
Q2 		$22K Buy
+1,390
New +$23.1K 0.05% 50

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Cornerstone Advisors (Washington)'s NVO Position: Q3 2020 in Review

Cornerstone Advisors (Washington) increased its Novo Nordisk (NVO) stake by 1.1% in Q3 2020, buying an estimated $5.47K and bringing the position to 14,666 shares worth $509K. The position accounts for 0.05% of the portfolio, ranked #44.

Cornerstone Advisors (Washington) first reported a position in NVO in Q2 2013 and has held it in 30 quarters since. The position peaked at $538K in Q3 2015. 660 funds tracked by Wall St. Rank hold NVO as of Q3 2020.

  • Cornerstone Advisors (Washington) held 14,666 shares of Novo Nordisk worth $509K as of Q3 2020.
  • Cornerstone Advisors (Washington) bought 164 Novo Nordisk shares in Q3 2020, an estimated $5.47K.
  • Novo Nordisk made up 0.05% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #44 holding.
  • Cornerstone Advisors (Washington) first reported a position in Novo Nordisk in Q2 2013 and has held it in 30 quarters since.
  • Cornerstone Advisors (Washington)'s Novo Nordisk position peaked at $538K in Q3 2015.
  • 660 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.